They spend more on marketing than they ever do on developing drugs.
This isn't even a pharma company, I highly doubt this guy will develop any new drugs.
Turing Pharmaceuticals AG is a privately-held biopharmaceutical company with offices in Zug Switzerland and New York, New York. Turing focuses on developing and commercializing innovative treatments for serious diseases and conditions across a broad range of therapeutic areas, for which there are currently limited or no treatment options. Products being developed include intranasal ketamine for a variety of mood disorders and Syntocinon® (oxytocin nasal solution) for multiple indications. Daraprim (pyrimethamine) for the treatment of Toxoplasmosis in combination with sulfonamide and Vecamyl® (mecamylamine HCl tablets) for hypertension are Turing’s first commercial products.
They spend more on marketing than they ever do on developing drugs.
Pharmaceuticals make more profits than banks and any other industry. I don't know how anyone can use the argument that they spend so much on R&D and that's why they sell them at large prices.
Turns out the guy is a leader of a LoL team and they are now trying to work out if he is fit to lead a LoL team.
Except maybe the oil industry or mobile phone companies (don't shell and BP hold the records for the biggest profits or did Apple just beat that record?). However unlike banks, pharmaceutical companies invest a third back into r&d.
But I agree, the profits are huge in general.
This isn't about profit, it is about the price hike.
Totally hypothetical but take treatment vs cure as an example. It'd be more profitable to develop a treatment to a disease someone will have to take for years rather than a magic bullet to cure it on one hit. If they had both is there anything to stop them just releasing an inferior drug that will need to be taken for a lot longer?
I am not sure which is worse, the price hike or the people defending it.
Cause, just like Anadin there will be some customers prepared to pay more than 10 times the cost of the generic ones.
That's how the GD jury makes its decisions.
The little ***** CEO's excuse for the price hike is that the drug is undervalued compared to other life saving drugs.